BigOmics
Develops interactive bioinformatics software platforms to help life scientists easily visualize and analyze omics data.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | N/A | Early VC | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 40 % | 43 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
BigOmics Analytics operates in the bioinformatics sector, providing a self-service platform for visual analytics of Big Omics data. The company serves biologists, bioinformaticians, and life scientists who are overwhelmed by the vast amounts of data generated from omics experiments. BigOmics Analytics addresses the critical need for efficient data analysis tools by offering an Analytics-as-a-Service (AaaS) model, which allows users to access their platform anytime and anywhere via the cloud. The platform features interactive dashboards that enable users to explore data, answer queries, and gain insights quickly and easily. The business model revolves around subscription fees for access to the platform, with different pricing tiers based on the level of service and features required. By simplifying the data analysis process, BigOmics Analytics helps its clients accelerate scientific discoveries and improve healthcare outcomes.
Keywords: bioinformatics, visual analytics, Big Omics data, self-service platform, cloud-based, interactive dashboards, life sciences, data exploration, AaaS, scientific discoveries.